Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Fyn & Pyk2 Kinase Inhibition for Alzheimer's Disease
Stephen Strittmatter, M.D., Ph.D. -
Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE
Jeffrey Bender, M.D. -
NCS1 - A New Target for Mood Disorders and Wolfram Syndrome
Barbara Ehrlich, Ph.D. -
Cell Permeable Miniature Proteins
Alanna Schepartz, Ph.D. -
PremieBreathe: Low-Cost Breathing Aid for Newborns
Anjelica Gonzalez, PhD -
A Probiotic Gene Cassette for Ulcerative Colitis Treatment
Jason Crawford, PhD, Associate Professor of Chemistry and Associate Professor of Microbial Pathogenesis -
A Simple Test to Predict Benefit of Antibiotics for Upper Respiratory Tract Infections
Ellen F Foxman, MD, PhD -
Paci-PHI: Evolution-Proof Therapy Against MDR Bacterial Pathogens
Paul Turner, Ph.D.